Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Axis NIFTY Healthcare ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited18.3534224463.8989
Domestic EquitiesDivi's Laboratories Limited8.118026911.7245
Domestic EquitiesMax Healthcare Institute Limited8.1041157661.7216
Domestic EquitiesApollo Hospitals Enterprise Limited8.026521801.7051
Domestic EquitiesDr. Reddy's Laboratories Limited7.8214129171.6615
Domestic EquitiesCipla Limited7.5606119131.6061
Domestic EquitiesLupin Limited5.563151341.1818
Domestic EquitiesFortis Healthcare Limited4.8962110341.0401
Domestic EquitiesTorrent Pharmaceuticals Limited4.518322150.9598
Domestic EquitiesLaurus Labs Limited4.166882280.8852
Domestic EquitiesAurobindo Pharma Limited3.402159220.7227
Domestic EquitiesAlkem Laboratories Limited3.289212390.6987
Domestic EquitiesGlenmark Pharmaceuticals Limited3.207631890.6814
Domestic EquitiesBiocon Limited2.7662150750.5876
Domestic EquitiesMankind Pharma Limited2.534023950.5383
Domestic EquitiesZydus Lifesciences Limited2.299152990.4884
Domestic EquitiesIPCA Laboratories Limited2.118129430.4500
Domestic EquitiesAbbott India Limited1.38621110.2945
Domestic EquitiesPiramal Pharma Limited0.9655131370.2051
Domestic EquitiesSyngene International Limited0.801740340.1703
Total 99.8980 21.2216
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd0.2363 0.0502
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.1343 -0.0285
Total 0.1020 0.0217
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.